Literature DB >> 1300191

International SMA consortium meeting. (26-28 June 1992, Bonn, Germany).

T L Munsat1, K E Davies.   

Abstract

Mesh：

Year:  1992        PMID： 1300191     DOI： 10.1016/s0960-8966(06)80015-5

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN： 0960-8966            Impact factor:   4.296


× No keyword cloud information.
  166 in total

1.  Molecular study of spinal muscular atrophy patients with hybrid genes in Bulgaria.

Authors:  I Kremensky; S Jankova; E Bochukova; M Uzunova; I Litvinenko; A Jordanova
Journal:  J Inherit Metab Dis       Date:  1999-05       Impact factor: 4.982

2.  IPLEX administration improves motor neuron survival and ameliorates motor functions in a severe mouse model of spinal muscular atrophy.

Authors:  Michela Murdocca; Arianna Malgieri; Andrea Luchetti; Luciano Saieva; Gabriella Dobrowolny; Elvira de Leonibus; Antonio Filareto; Maria Chiara Quitadamo; Giuseppe Novelli; Antonio Musarò; Federica Sangiuolo
Journal:  Mol Med       Date:  2012-09-25       Impact factor: 6.354

3.  Htra2-beta 1 stimulates an exonic splicing enhancer and can restore full-length SMN expression to survival motor neuron 2 (SMN2).

Authors:  Y Hofmann; C L Lorson; S Stamm; E J Androphy; B Wirth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

4.  Spinal muscular atrophy--type I.

Authors:  M K M Hardart; R D Truog
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

5.  Carrier incidence for spinal muscular atrophy in southern Chinese.

Authors:  Vivian Chan; Ben Yip; Irene Yam; Patrick Au; Che-Kit Lin; Virginia Wong; Tai-Kwong Chan
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

6.  Failure of lower motor neuron radial outgrowth precedes retrograde degeneration in a feline model of spinal muscular atrophy.

Authors:  Erin N Wakeling; Béatrice Joussemet; Patrick Costiou; Dominique Fanuel; Philippe Moullier; Martine Barkats; John C Fyfe
Journal:  J Comp Neurol       Date:  2012-06-01       Impact factor: 3.215

7.  Clinical utility gene card for: proximal spinal muscular atrophy.

Authors:  Sabine Rudnik-Schöneborn; Thomas Eggermann; Wolfram Kress; Henny H Lemmink; Jan-Maarten Cobben; Klaus Zerres
Journal:  Eur J Hum Genet       Date:  2012-04-18       Impact factor: 4.246

Review 8.  Applicability of histone deacetylase inhibition for the treatment of spinal muscular atrophy.

Authors:  Sebastian Lunke; Assam El-Osta
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

9.  Diagnosis of spinal muscular atrophy in an SMN non-deletion patient using a quantitative PCR screen and mutation analysis.

Authors:  D W Parsons; P E McAndrew; P S Allinson; W D Parker; A H Burghes; T W Prior
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

10.  Genetic correction of human induced pluripotent stem cells from patients with spinal muscular atrophy.

Authors:  Stefania Corti; Monica Nizzardo; Chiara Simone; Marianna Falcone; Martina Nardini; Dario Ronchi; Chiara Donadoni; Sabrina Salani; Giulietta Riboldi; Francesca Magri; Giorgia Menozzi; Clara Bonaglia; Federica Rizzo; Nereo Bresolin; Giacomo P Comi
Journal:  Sci Transl Med       Date:  2012-12-19       Impact factor: 17.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.